Search results
Analysts Hunt for Undervalued Biotech Stocks
Digital Journal· 11 hours ago(NASDAQ: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products. The Company's diversified pipeline includes ...
Injectables for high blood pressure are in the works. Could they mean no more daily pills?
Medical Xpress· 2 days agoAbout one-third of adults have high blood pressure. Two-thirds of these have uncontrolled high blood...
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?
Zacks via Yahoo Finance Canada· 5 days agoSilence Therapeutics (SLN) witnessed a jump in share price last session on above-average trading...
ReciBioPharm’s Edita Botonjic-Sehic on analytics, AI, and continuous RNA manufacturing
BioPharma-Reporter· 6 days agoRNA therapeutics have emerged as a transformative approach to treating many conditions, but the...